Literature DB >> 12682433

Quantification of 20-hydroxyeicosatetraenoic acid by colorimetric competitive enzyme linked immunosorbent assay.

Harry E Grates1, Richard M McGowen, Smiti V Gupta, John R Falck, Thomas R Brown, Denis M Callewaert, Diane M Sasaki.   

Abstract

Analysis of 20-hydroxyeicosatetraenoic acid (20-HETE), a potent vasoconstrictor produced by the cytochrome P450 pathway, presently requires high-performance liquid chromatography (HPLC) and gas chromatography/ mass spectrometry (GC/MS). To simplify 20-HETE analysis, competitive ELISAs were developed using polyclonal anti-20-HETE coated ELISA plates to which free 20-HETE and 20-HETE conjugated to horseradish peroxidase (HRP) or alkaline phosphatase (AP) were added. Assays were developed with and without a pro prietary enhancer solution which allows for the extraction-free measurement of 20-HETE in urine samples. The bound 20-HETE-HRP or 20-HETE-AP was detected using 3,3 ,5,5, -tetramethylbenzidine and p-nitrophenyl phosphate, respectively. Sensitivities expressed as 80% B/B0, were 0.1 ng/ml for the HRP assay, and 0 5 ng/ml for the AP assay, with r2 = 0 99 for both formats. Of the 17 lipids tested for cross-reactivity, arachidonic acid showed the highest (0.32%) followed by racemic 5-HETE (0.07%) and 8,9-dihydroxyeicosatrienoic acid (DHET) (0.04%). Preliminary validation experiments examining serum and urine concentrations of 20-HETE yield values that fall within the ranges established by GC/MS in the literature. These ELISAs provide simple and inexpensive methods for the analysis of 20-HETE in biological samples.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682433     DOI: 10.1007/BF02970140

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  8 in total

1.  A simple, non-chromatographic purification procedure for monoclonal antibodies. Isolation of monoclonal antibodies against cytochrome P450 isozymes.

Authors:  L M Reik; S L Maines; D E Ryan; W Levin; S Bandiera; P E Thomas
Journal:  J Immunol Methods       Date:  1987-06-26       Impact factor: 2.303

2.  The use of carbodiimides in the preparation of immunizing conjugates.

Authors:  S Bauminger; M Wilchek
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

3.  Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles.

Authors:  J D Imig; A P Zou; D E Stec; D R Harder; J R Falck; R J Roman
Journal:  Am J Physiol       Date:  1996-01

Review 4.  20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure.

Authors:  J C McGiff; J Quilley
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-03       Impact factor: 2.894

5.  20-Hydroxyeicosatetraenoic acid is excreted as a glucuronide conjugate in human urine.

Authors:  C Prakash; J Y Zhang; J R Falck; K Chauhan; I A Blair
Journal:  Biochem Biophys Res Commun       Date:  1992-06-15       Impact factor: 3.575

6.  Production of 20-HETE and its role in autoregulation of cerebral blood flow.

Authors:  D Gebremedhin; A R Lange; T F Lowry; M R Taheri; E K Birks; A G Hudetz; J Narayanan; J R Falck; H Okamoto; R J Roman; K Nithipatikom; W B Campbell; D R Harder
Journal:  Circ Res       Date:  2000-07-07       Impact factor: 17.367

Review 7.  Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids.

Authors:  R J Roman; K G Maier; C W Sun; D R Harder; M Alonso-Galicia
Journal:  Clin Exp Pharmacol Physiol       Date:  2000-11       Impact factor: 2.557

Review 8.  P-450 metabolites of arachidonic acid in the control of cardiovascular function.

Authors:  Richard J Roman
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

  8 in total
  1 in total

1.  Rapid, simultaneous quantitation of mono and dioxygenated metabolites of arachidonic acid in human CSF and rat brain.

Authors:  Tricia M Miller; Mark K Donnelly; Elizabeth A Crago; Dana M Roman; Paula R Sherwood; Michael B Horowitz; Samuel M Poloyac
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-10-14       Impact factor: 3.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.